Hutchmed Drc Stock Performance
| HCM Stock | USD 15.00 0.25 1.64% |
The company retains a Market Volatility (i.e., Beta) of 0.4, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, HUTCHMED DRC's returns are expected to increase less than the market. However, during the bear market, the loss of holding HUTCHMED DRC is expected to be smaller as well. At this point, HUTCHMED DRC has a negative expected return of -0.0316%. Please make sure to check out HUTCHMED DRC's expected short fall, and the relationship between the value at risk and daily balance of power , to decide if HUTCHMED DRC performance from the past will be repeated at some future point.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (1.64) | Five Day Return (2.66) | Year To Date Return 9.89 | Ten Year Return 11.11 | All Time Return 11.11 |
Last Split Factor 10:1 | Last Split Date 2019-05-30 |
1 | isolved Elevates the Customer Experience Through Innovation, Connection and Care | 11/13/2025 |
2 | ADP Announces 2026 HCM Distinction Award Finalists | 12/09/2025 |
3 | AI Partnerships Versus Slowing HCM Growth Might Change The Case For Investing In Workday | 12/16/2025 |
4 | Nyxoah Announces Issuance of First Tranche of Convertible Bonds | 12/19/2025 |
5 | HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma | 12/29/2025 |
6 | Wall Street Analysts Predict a 55.93 percent Upside in HUTCHMED Heres What You Should Know | 01/07/2026 |
7 | Homeland Provides Clarification on Prior Investor Relations Services Agreement with HoldCo Markets | 01/15/2026 |
8 | isolved Report Nearly 60 percent of Brokers See Rising Demand for Compliance Services in 2026 | 01/21/2026 |
9 | Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy | 01/27/2026 |
| Begin Period Cash Flow | 283.6 M | |
| Total Cashflows From Investing Activities | -96.1 M |
HUTCHMED DRC Relative Risk vs. Return Landscape
If you would invest 1,544 in HUTCHMED DRC on November 4, 2025 and sell it today you would lose (44.00) from holding HUTCHMED DRC or give up 2.85% of portfolio value over 90 days. HUTCHMED DRC is generating negative expected returns assuming volatility of 1.8013% on return distribution over 90 days investment horizon. In other words, 16% of stocks are less volatile than HUTCHMED, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
HUTCHMED DRC Target Price Odds to finish over Current Price
The tendency of HUTCHMED Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.00 | 90 days | 15.00 | about 25.52 |
Based on a normal probability distribution, the odds of HUTCHMED DRC to move above the current price in 90 days from now is about 25.52 (This HUTCHMED DRC probability density function shows the probability of HUTCHMED Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon HUTCHMED DRC has a beta of 0.4. This usually indicates as returns on the market go up, HUTCHMED DRC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding HUTCHMED DRC will be expected to be much smaller as well. Additionally HUTCHMED DRC has an alpha of 0.0068, implying that it can generate a 0.006797 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). HUTCHMED DRC Price Density |
| Price |
Predictive Modules for HUTCHMED DRC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HUTCHMED DRC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HUTCHMED DRC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
HUTCHMED DRC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. HUTCHMED DRC is not an exception. The market had few large corrections towards the HUTCHMED DRC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold HUTCHMED DRC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of HUTCHMED DRC within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0.40 | |
σ | Overall volatility | 0.79 | |
Ir | Information ratio | -0.0076 |
HUTCHMED DRC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HUTCHMED DRC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HUTCHMED DRC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HUTCHMED DRC generated a negative expected return over the last 90 days | |
| Latest headline from globenewswire.com: Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy |
HUTCHMED DRC Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HUTCHMED Stock often depends not only on the future outlook of the current and potential HUTCHMED DRC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HUTCHMED DRC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 174.6 M | |
| Cash And Short Term Investments | 836.1 M |
HUTCHMED DRC Fundamentals Growth
HUTCHMED Stock prices reflect investors' perceptions of the future prospects and financial health of HUTCHMED DRC, and HUTCHMED DRC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HUTCHMED Stock performance.
| Return On Equity | 0.47 | ||||
| Return On Asset | -0.0081 | ||||
| Profit Margin | 0.78 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 1.33 B | ||||
| Shares Outstanding | 171.9 M | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 2.10 X | ||||
| Price To Sales | 4.50 X | ||||
| Revenue | 630.2 M | ||||
| Gross Profit | 53.76 M | ||||
| EBITDA | 14.11 M | ||||
| Net Income | 37.73 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 89.82 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 1.43 X | ||||
| Cash Flow From Operations | 497 K | ||||
| Earnings Per Share | 2.65 X | ||||
| Market Capitalization | 2.71 B | ||||
| Total Asset | 1.27 B | ||||
| Retained Earnings | (833.17 M) | ||||
| Working Capital | 689.99 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
About HUTCHMED DRC Performance
By examining HUTCHMED DRC's fundamental ratios, stakeholders can obtain critical insights into HUTCHMED DRC's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that HUTCHMED DRC is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 60.64 | 91.97 | |
| Return On Tangible Assets | 0.03 | 0.04 | |
| Return On Capital Employed | (0.05) | (0.05) | |
| Return On Assets | 0.03 | 0.04 | |
| Return On Equity | 0.06 | 0.06 |
Things to note about HUTCHMED DRC performance evaluation
Checking the ongoing alerts about HUTCHMED DRC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HUTCHMED DRC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HUTCHMED DRC generated a negative expected return over the last 90 days | |
| Latest headline from globenewswire.com: Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy |
- Analyzing HUTCHMED DRC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HUTCHMED DRC's stock is overvalued or undervalued compared to its peers.
- Examining HUTCHMED DRC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HUTCHMED DRC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HUTCHMED DRC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HUTCHMED DRC's stock. These opinions can provide insight into HUTCHMED DRC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Pharmaceuticals sector continue expanding? Could HUTCHMED diversify its offerings? Factors like these will boost the valuation of HUTCHMED DRC. Market participants price HUTCHMED higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every HUTCHMED DRC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 16.333 | Earnings Share 2.65 | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
Understanding HUTCHMED DRC requires distinguishing between market price and book value, where the latter reflects HUTCHMED's accounting equity. The concept of intrinsic value—what HUTCHMED DRC's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push HUTCHMED DRC's price substantially above or below its fundamental value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, HUTCHMED DRC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.